Director/PDMR Shareholding

Flomerics Group PLC
04 May 2007



                              Flomerics Group PLC

Grant of Options

Flomerics Group PLC ("the Company") announces that it has granted options for
nil consideration to Dr Gary Carter, Chief Executive Officer, under the
Flomerics Group Executive Share Option Plan 2006, further details of which are
as follows:

Number of options awarded over ordinary shares of 1 p each      100,000

Grant date                                                      3 May 2007

Exercise price (based on closing share price as at 2 May 2007)  86 pence

Exercise period                                                 Between 3 years 
                                                                and 10 years 
                                                                from the grant 
                                                                date

These options are subject to a performance condition based on the average
adjusted Profit Before Tax of the Group over three financial years commencing
with the financial year in which the options are granted.

Following this award, Dr Carter holds options over 300,000 ordinary shares of 1p
each in the Company.

For further information please contact:

Flomerics Group PLC                                   020 8487 3000
Chris Ogle (Finance Director)

Oriel Securities Limited                              020 7710 7600
Andrew Edwards



                      This information is provided by RNS
            The company news service from the London Stock Exchange